| Tag | Content |
|---|
EnhancerAtlas ID | HS099-03713 |
Organism | Homo sapiens |
Tissue/cell | HSMMtube |
Coordinate | chr11:9638190-9640240 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| Gata4 | MA0482.1 | chr11:9639822-9639833 | TCTTATCTCCC | + | 6.62 | | KLF4 | MA0039.3 | chr11:9638632-9638643 | CCACACCCTGT | + | 6.14 |
|
| | Number of super-enhancer constituents: 5 | ID | Coordinate | Tissue/cell |
| SE_10398 | chr11:9633380-9640226 | CD19_Primary | | SE_11340 | chr11:9633112-9642446 | CD20 | | SE_58994 | chr11:9615495-9667034 | Ly3 | | SE_60402 | chr11:9590028-9649178 | DHL6 | | SE_62122 | chr11:9621561-9641974 | Toledo |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 3 | Chromosome | Start | End |
| chr11 | 9639489 | 9640012 | | chr11 | 9638482 | 9638715 | | chr11 | 9639557 | 9639822 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH11I009611 | chr11 | 9633385 | 9641855 |
|
Enhancer Sequence | AGAGAGGGTC TTGCTCTGTT TCCCAGGCTA CAGTGCAGTG GTGCTATCAT GTCTCATTGC 60
AGCCTCAACC TCTCAGGCTC AAGCAATCCT CCGGTCCCAG CCTTTCAAGT GGCTGGGACT 120
ACAGGTATAC TCCACCACAT TTAGCTAATT TTTTTTTCTT TTTTTGTAGC GATGGGGGGT 180
CTCATTATGT TGCCCAGGCT GGTCTCAAAC TCCTGAACTC AAGAGATCCT CCTGCCTTCG 240
CCTCCCAAAG TGTTCGAATT ACAGGTGTGA GCCATTGTGC CTGGCTGGGG AAACTGCTAT 300
CTAGGCAAAG GAAACATGAT TGCAAAGGCC TTGAGGTAGA AGTGTGCTTG GTGTGTTGAA 360
GGAGGCCAGT GTGACAGGAG TGGAGTGGGC CAGGAGGAGT GAAAGCTGTT TTGAGTAGGA 420
AGGTGAGTCG TAAGTGGTGG GCCCACACCC TGTGAGGCCT ATAGGCTTTC ACTCTGAGAA 480
GAAGAGCTGT TAAAGGGTTT TGTGCAGAGG AATGAGATAC TCTGATTTTA AAAGAATGAA 540
TGTGTCGATG GAGAACAGAC AGCCAGAGTT TGGAGATTGT TACAATAATC CAGGCAAGAG 600
ATGAAGCCCT TCTTTGGAGT GGGACATGGT GGTGTGAGTG ATAGGGATAG CCTGGGGATG 660
GGGTTTTTTT TGTTTGTTTT TGAGATGGAG ATTCACTCTT GTTGCCCAGG CTGGAGTGCA 720
ATGGGACGAT CTTGGCTCAC TGCAACCTCC GCCTCCCTGG TTCAAGCGAT TCTCCTGTCT 780
CAGCCTCCTG AGTAGCTGGG ATTACAGGCA TGTGCCACCA CGCCTGGCTA ATTTTGTATT 840
TTTAGTAGAG ATGGGGTTTC TCTTGGTTGG TCAGGCTGGT CTCTAACTCC TGACCTCAGG 900
TGATCTGCCA ATCTTGGCCT CCCCAAGTGC TGGGATTACA GGTGTGAGCC ACCATGCGTG 960
GCCCTAATTT TTGTCTTTTT AGTAGACGGG GTTTCACCAT GTTGGCCAGG TTGGTCTCGA 1020
ACTCCTGACC GCTGGTGATC CACCCACCTC AGCCTCCTAA AGTGCTGGGA TTACAGACGT 1080
GAGCCACAGC GCCCTGGGGA CGGTTTTAAT AGGATTTGTT GATGGTTTAG AAGTCAGAAA 1140
GGGAAGAGTC AAAGATGACA TCAAGCTTTA GGAAGAATGG AACTGCTATT GTGTTTTCTG 1200
AGTTTTGTTG TTGTTTGTTC ATTTGCTTGT GTTCTGTGTA GGGAGATGGG GAATTAGGAA 1260
TTTAGTTTTG AACATATTAA ATTTGAGATG CCTGTTAGAA AGCTAAGCGA ATAAGTCAAG 1320
TAGGCAGTGA AATATAAGAA CTTGAAGTTT ACGGGAGAAG TCAGAGCTGA TTTTGGAGAC 1380
ATGAGTGAGG ATATATTTAA AGCATGAAAT GGCATGAGAT CCAGCCCAGA CTTCTCTCCC 1440
AATCATTTAT CCGGCTGTCT ACTTGACATC ACTACTTGGA TGTCTAAAAG ACAACTCAAG 1500
CTCAAAACAT CCAAAACAAC ATCTGATCTT AACTCCCCTA AACAATTCCA CCCGTAGCCT 1560
CGCCCATCTC AGTTAATGAT GTCACCATTC TTTCATTGCT CAGACAAAAT CCTGGAGTGA 1620
CTTTACTTTT TCTCTTATCT CCCACATTTA ATTGGTTAGG AGGTTCTCTT GGCTCTGCCT 1680
TGAAAATATA TTCAGAATCC AAACGCTTCT TACCACCTTC ATTGCTACCA TCCAGATCAG 1740
AGCTGCCATT GGTTGTTTCT TGCCTGGCTT ACTCCTAACA ATTTCTCTGC TTCTGCAACT 1800
GGCCTTCCCC ATCCCCGACC ACTCTGTTCT CAACAGAGGG ATTTTAAAAA AACCTGTCAG 1860
ATCACGTCCC TCCTCTGCTC AAAACCCTCC AAACAGCTTG CCGTTTCAGA GTAAAAGACA 1920
AAGTCCTGGC TGGGCACAGT GGCTCATGCC TGTAATCCCA GCACTTTGGG AGGCCAAGTG 1980
GGTGGATCAT GAGGTCAGGA GATCGAGAAC ATCCTGGCCA ACATGGTGAA ACTCTGTCTC 2040
TACTAAAATA 2050
|
